Disrupting ASD Treatment: Opportunities & Challenges

There are significant opportunities and challenges for health care provider and payer organizations in the autism spectrum disorder (ASD) market, which is expected to reach a $2.23 billion valuation by 2022 (see U.S. Autism Treatment Market). First, consider that incidence rates continue to climb with one in 40 children ages 3 to 17 in the U.S. diagnosed with ASD (see The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children), whose care costs 4.1 to 6.2 times more than those without it. Estimates for children with the diagnosis range from $11.5 billion to . . .